Cargando…
Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma
BACKGROUND: To improve early diagnosis and chemotherapy efficacy monitoring in primary central nervous system lymphoma (PCNSL), cerebrospinal fluid (CSF) exosomal microRNA (miRNA) studies were performed. METHOD: Small RNA sequencing was performed to identify candidate exosomal miRNAs as CSF biopsy b...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654293/ https://www.ncbi.nlm.nih.gov/pubmed/37971595 http://dx.doi.org/10.1007/s12672-023-00812-1 |
_version_ | 1785147827804962816 |
---|---|
author | Hu, Yao Zhang, Qingyun Wu, Zhiyuan Chen, Kun Xu, Xiao Ma, Weizhe Chen, Bobin Jin, Limin Guan, Ming |
author_facet | Hu, Yao Zhang, Qingyun Wu, Zhiyuan Chen, Kun Xu, Xiao Ma, Weizhe Chen, Bobin Jin, Limin Guan, Ming |
author_sort | Hu, Yao |
collection | PubMed |
description | BACKGROUND: To improve early diagnosis and chemotherapy efficacy monitoring in primary central nervous system lymphoma (PCNSL), cerebrospinal fluid (CSF) exosomal microRNA (miRNA) studies were performed. METHOD: Small RNA sequencing was performed to identify candidate exosomal miRNAs as CSF biopsy biomarkers from two patients with de novo PCNSL and two patients in remission after chemotherapy. miR-200c and miR-141 expression in CSF exosomes was further validated using relative quantitative real-time polymerase chain reaction in patients with PCNSL (n = 20), patients with other neurological diseases (n = 10), and normal subjects (n = 10). Receiver operating characteristic (ROC) curve analyses of miR-200c and miR-141 in the diagnosis and prediction of chemotherapy efficacy in PCNSL were performed in patients treated with methotrexate. Additionally, bioinformatics tools were utilized to predict the potential targets of miR-200c and miR-141. RESULTS: Exosomal miR-200c and miR-141 levels in CSF from patients with PCNSL were significantly lower than those in control subjects. Importantly, miR-200c and miR-141 were upregulated in patients with PCNSL after chemotherapy (P = 0.002). There was a significant correlation between the levels of miR-141 and IL-10 in CSF (P = 0.04). The combination of miR-200c and miR-141 yielded an area under the ROC curve of 0.761 for distinguishing PCNSL with sensitivity and specificity of 60.0% and 96.7%, respectively. The potential target genes of miR-200c and miR-141 in PCNSL included ATP1B3, DYNC1H1, MATR3, NUCKS1, ZNF638, NUDT4, RCN2, GNPDA1, ZBTB38, and DOLK. CONCLUSION: Collectively, miR-200c and miR-141 are likely to be upregulated in CSF exosomes after chemotherapy in patients with PCNSL, highlighting their potential as reliable liquid biopsy biomarkers for PCNSL diagnosis and chemotherapy efficacy monitoring. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-023-00812-1. |
format | Online Article Text |
id | pubmed-10654293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-106542932023-11-16 Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma Hu, Yao Zhang, Qingyun Wu, Zhiyuan Chen, Kun Xu, Xiao Ma, Weizhe Chen, Bobin Jin, Limin Guan, Ming Discov Oncol Research BACKGROUND: To improve early diagnosis and chemotherapy efficacy monitoring in primary central nervous system lymphoma (PCNSL), cerebrospinal fluid (CSF) exosomal microRNA (miRNA) studies were performed. METHOD: Small RNA sequencing was performed to identify candidate exosomal miRNAs as CSF biopsy biomarkers from two patients with de novo PCNSL and two patients in remission after chemotherapy. miR-200c and miR-141 expression in CSF exosomes was further validated using relative quantitative real-time polymerase chain reaction in patients with PCNSL (n = 20), patients with other neurological diseases (n = 10), and normal subjects (n = 10). Receiver operating characteristic (ROC) curve analyses of miR-200c and miR-141 in the diagnosis and prediction of chemotherapy efficacy in PCNSL were performed in patients treated with methotrexate. Additionally, bioinformatics tools were utilized to predict the potential targets of miR-200c and miR-141. RESULTS: Exosomal miR-200c and miR-141 levels in CSF from patients with PCNSL were significantly lower than those in control subjects. Importantly, miR-200c and miR-141 were upregulated in patients with PCNSL after chemotherapy (P = 0.002). There was a significant correlation between the levels of miR-141 and IL-10 in CSF (P = 0.04). The combination of miR-200c and miR-141 yielded an area under the ROC curve of 0.761 for distinguishing PCNSL with sensitivity and specificity of 60.0% and 96.7%, respectively. The potential target genes of miR-200c and miR-141 in PCNSL included ATP1B3, DYNC1H1, MATR3, NUCKS1, ZNF638, NUDT4, RCN2, GNPDA1, ZBTB38, and DOLK. CONCLUSION: Collectively, miR-200c and miR-141 are likely to be upregulated in CSF exosomes after chemotherapy in patients with PCNSL, highlighting their potential as reliable liquid biopsy biomarkers for PCNSL diagnosis and chemotherapy efficacy monitoring. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-023-00812-1. Springer US 2023-11-16 /pmc/articles/PMC10654293/ /pubmed/37971595 http://dx.doi.org/10.1007/s12672-023-00812-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Hu, Yao Zhang, Qingyun Wu, Zhiyuan Chen, Kun Xu, Xiao Ma, Weizhe Chen, Bobin Jin, Limin Guan, Ming Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma |
title | Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma |
title_full | Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma |
title_fullStr | Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma |
title_full_unstemmed | Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma |
title_short | Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma |
title_sort | exosomal mir-200c and mir-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654293/ https://www.ncbi.nlm.nih.gov/pubmed/37971595 http://dx.doi.org/10.1007/s12672-023-00812-1 |
work_keys_str_mv | AT huyao exosomalmir200candmir141ascerebrospinalfluidbiopsybiomarkersfortheresponsetochemotherapyinprimarycentralnervoussystemlymphoma AT zhangqingyun exosomalmir200candmir141ascerebrospinalfluidbiopsybiomarkersfortheresponsetochemotherapyinprimarycentralnervoussystemlymphoma AT wuzhiyuan exosomalmir200candmir141ascerebrospinalfluidbiopsybiomarkersfortheresponsetochemotherapyinprimarycentralnervoussystemlymphoma AT chenkun exosomalmir200candmir141ascerebrospinalfluidbiopsybiomarkersfortheresponsetochemotherapyinprimarycentralnervoussystemlymphoma AT xuxiao exosomalmir200candmir141ascerebrospinalfluidbiopsybiomarkersfortheresponsetochemotherapyinprimarycentralnervoussystemlymphoma AT maweizhe exosomalmir200candmir141ascerebrospinalfluidbiopsybiomarkersfortheresponsetochemotherapyinprimarycentralnervoussystemlymphoma AT chenbobin exosomalmir200candmir141ascerebrospinalfluidbiopsybiomarkersfortheresponsetochemotherapyinprimarycentralnervoussystemlymphoma AT jinlimin exosomalmir200candmir141ascerebrospinalfluidbiopsybiomarkersfortheresponsetochemotherapyinprimarycentralnervoussystemlymphoma AT guanming exosomalmir200candmir141ascerebrospinalfluidbiopsybiomarkersfortheresponsetochemotherapyinprimarycentralnervoussystemlymphoma |